Parameters | Controls | Patients groups | |
---|---|---|---|
 | (n = 15) | With chelation [Group I] (n = 34) | Without chelation [Group II] (n = 35) |
Albumin/Cr (mg/mmol) | 1.56 ± 0.51 | 68.19 ± 79.85 | 63.35 ± 79.89 |
Range | (0.50-2.00) | (1.20-216.00) | (0.50-300.00) |
Significance | Â | P < 0.003 | P < 0.006, *P < 0.779 |
Normal albumin, < 2.5 mg/mmol.creatinine | 15 (100.00%) | 2 (5.90%) | 10 (28.60%) |
Microalbuminurea,2.5-30 mg/mmol.creatinine | - | 16 (47.10%) | 9 (25.70%) |
Proteinuria, > 30 mg/mmol.creatinine | - | 16 (47.10%) | 16 (45.70%) |
NAG/Cr (U/mg) | 7.47 ± 2.28 | 15.00 ± 6.17 | 13.84 ± 7.60 |
Range | (3.00-9.50) | (6.00-25.00) | (3.00-30.00) |
Significance | Â | P < 0.000 | P < 0.002, *P < 0.453 |
β 2 MG/Cr (ug/mg) | 11.40 ± 6.70 | 70.90 ± 71.40 | 65.40 ± 74.00 |
Range | (1.80-22.00) | (3.00-220.00) | (0.90-280.00) |
Significance | Â | P < 0.005 | P < 0.010, *P < 0.730 |
Uric acid (mg/dL) | 25.20 ± 5.62 | 38.97 ± 18.53 | 36.86 ± 17.05 |
Range | (16.00-32.00) | (15.00-70.00) | (16.00-70.00) |
Significance | Â | P < 0.008 | P < 0.023, *P < 0.593 |
Calcium (mg/dL) | 9.01 ± 1.20 | 13.24 ± 4.53 | 12.63 ± 5.26 |
Range | (7.50-23.00) | (7.50-23.00) | (7.00-25.00) |
Significance | Â | P < 0.003 | P < 0.011, *P < 0.569 |
Inorganic phosphorus (mg/dL) | 11.83 ± 7.42 | 48.32 ± 38.83 | 42.53 ± 38.04 |
Range | (6.00-25.00) | (6.00-110.00) | (5.00-120.00) |
Significance | Â | P < 0.001 | P < 0.006, *P < 0.495 |
MDA/Cr (nmol/mg) | 13.57 ± 3.69 | 21.29 ± 9.77 | 20.20 ± 12.93 |
Range | (2.50-18.00) | (10.00-41.00) | (4.00-50.00) |
Significance | Â | P < 0.021 | P < 0.045, *P < 0.671 |